These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 2429667)
1. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts. Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RR; Schretlen ED; van Laarhoven JP; De Bruyn CH Biochem Pharmacol; 1986 Oct; 35(20):3549-55. PubMed ID: 2429667 [TBL] [Abstract][Full Text] [Related]
2. Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages. Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RA; Schretlen ED Biochem Pharmacol; 1988 Jun; 37(12):2321-7. PubMed ID: 2455519 [TBL] [Abstract][Full Text] [Related]
3. 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Bökkerink JP; Stet EH; De Abreu RA; Damen FJ; Hulscher TW; Bakker MA; van Baal JA Biochem Pharmacol; 1993 Apr; 45(7):1455-63. PubMed ID: 7682415 [TBL] [Abstract][Full Text] [Related]
4. Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts. Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; Van Baal JM; De Vaan GA Biochem Pharmacol; 1986 Oct; 35(20):3557-64. PubMed ID: 2429668 [TBL] [Abstract][Full Text] [Related]
5. On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitro. Liliemark J; Pettersson B; Peterson C Leuk Res; 1992; 16(3):275-80. PubMed ID: 1373210 [TBL] [Abstract][Full Text] [Related]
6. [6-Mercaptopurine and methotrexate, rational use in sight after 35 years?]. Bökkerink JP; Schouten TJ; De Abreu RA; Lippens RJ; De Vaan GA; De Bruyn CH; Van Laarhoven JP Tijdschr Kindergeneeskd; 1984 Aug; 52(4):118-23. PubMed ID: 6593896 [TBL] [Abstract][Full Text] [Related]
7. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis? Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311 [TBL] [Abstract][Full Text] [Related]
8. [Biochemical and clinico-pharmacological aspects of antimetabolites in the treatment of leukemia]. Bökkerink JP; de Abreu RA; Lippens RJ; Schouten TJ; de Vaan GA Tijdschr Kindergeneeskd; 1988 Apr; 56(2):55-60. PubMed ID: 3287684 [TBL] [Abstract][Full Text] [Related]
9. Cell-kinetics and biochemical pharmacology of methotrexate and 6-mercaptopurine in human malignant T-lymphoblasts. Bökkerink JP; De Abreu RA; Stet EH; Damen FJ Klin Padiatr; 1992; 204(4):293-8. PubMed ID: 1518268 [TBL] [Abstract][Full Text] [Related]
10. Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineages. Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; van Baal JM; Schretlen ED; De Bruijn CH Biochem Pharmacol; 1988 Jun; 37(12):2329-38. PubMed ID: 2455520 [TBL] [Abstract][Full Text] [Related]
11. [Use of purine rescue pathways by L1210 cells exposed to methotrexate in vitro]. Buesa JM Rev Esp Oncol; 1982; 29(4):641-7. PubMed ID: 6085740 [TBL] [Abstract][Full Text] [Related]
12. Effects of methotrexate on nucleotide pools in normal human T cells and the CEM T cell line. Budzik GP; Colletti LM; Faltynek CR Life Sci; 2000; 66(23):2297-307. PubMed ID: 10855951 [TBL] [Abstract][Full Text] [Related]
13. Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblasts. Stet EH; De Abreu RA; Bökkerink JP; Vogels-Mentink TM; Lambooy LH; Trijbels FJ; Trueworthy RC Biochem Pharmacol; 1993 Aug; 46(3):547-50. PubMed ID: 8347177 [TBL] [Abstract][Full Text] [Related]
14. The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts. Vogt MH; Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Trijbels FJ Biochim Biophys Acta; 1993 Apr; 1181(2):189-94. PubMed ID: 7683208 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P). Moore EC; Hurlbert RB; Boss GR; Massia SP Biochem Pharmacol; 1989 Nov; 38(22):4045-51. PubMed ID: 2480792 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of CCRF-CEM human leukemic lymphoblasts by triciribine (tricyclic nucleoside, TCN, NSC-154020). Accumulation of drug in cells and comparison of effects on viability, protein synthesis and purine synthesis. Moore EC; Hurlbert RB; Massia SP Biochem Pharmacol; 1989 Nov; 38(22):4037-44. PubMed ID: 2480791 [TBL] [Abstract][Full Text] [Related]
17. Alteration of purine metabolism by AICA-riboside in human B lymphoblasts. Barankiewicz J; Jimenez R; Ronlov G; Magill M; Gruber HE Arch Biochem Biophys; 1990 Nov; 282(2):377-85. PubMed ID: 1700665 [TBL] [Abstract][Full Text] [Related]